Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- MicroEmissive Displ

4 Sep 2008 10:15

RNS Number : 7223C
Cazenove Capital Management Ltd
04 September 2008
 



  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION

Name of person dealing  (Note 1)

Cazenove Capital Management Ltd. 

 

Company dealt in

Microemissive Displays Group

 

Class of relevant security to which the dealings being disclosed relate (Note 2)

 

Ordinary GBP 0.01

Date of dealing

03/09/2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

6,486,571 10.93%

(2) Derivatives (other than options)

262,500 0.44%

(3) Options and agreements to purchase/sell

Total

6,749,071  11.37%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

Sale

610,860

0.0175

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)  NO

Date of disclosure

04/09/08

 

Contact name

Marta Foster

 

Telephone number

020 7155 5607

 

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUUUWGBUPRUBC
Date   Source Headline
14th Jan 201911:34 amRNSChange of Name
7th Jan 20197:00 amRNSTrading Update
14th Dec 20181:05 pmRNSHolding(s) in Company
13th Dec 20188:30 amRNSDirector/PDMR Shareholding
12th Dec 20181:24 pmRNSResults of General Meeting and Total Voting Rights
12th Dec 20187:00 amRNSResults of Open Offer
27th Nov 20183:35 pmRNSAI database exceeds 1 million images
26th Nov 20187:00 amRNSPlacing to raise £5.0m
23rd Nov 20183:56 pmRNSMedaPhor commences clinical trial for AnatomyGuide
13th Nov 20187:00 amRNSQuality control on ultrasound for HAPIN trial
9th Nov 20187:00 amRNSINTERGROWTH-21st Project the University of Oxford
10th Oct 20182:59 pmRNSHolding(s) in Company
9th Oct 20188:01 amRNSDirector/PDMR Shareholding
8th Oct 20187:00 amRNSPayment of deferred consideration
25th Jul 20187:00 amRNSHalf-year Report
23rd Jul 20187:00 amRNSMedaphor expands ScanNav AI pilot
7th Jun 20187:00 amRNSScanTrainer at Central Middlesex Hospital
30th May 20187:00 amRNSGrant of Options
29th May 20187:00 amRNSBodyWorks Eve installed at NYU School of Medicine
17th May 201810:54 amRNSResult of AGM
17th May 20187:00 amRNSAGM Statement
14th May 20187:00 amRNSScanNav AI software featured on ITV
24th Apr 20187:00 amRNSNotice of AGM
21st Mar 20187:00 amRNSFinal Results
5th Mar 20187:00 amRNSNotice of Results
21st Feb 20187:00 amRNSOpening of Hong Kong office
19th Feb 20187:00 amRNSLaunch of new Point-of-Care Ultrasound simulator
12th Feb 20187:00 amRNSPilot of ultrasound AI software for pregnancy scan
7th Feb 20187:00 amRNSInvestor presentation
5th Feb 20187:00 amRNSInnovate UK grant award confirmed
3rd Jan 20187:00 amRNSTrading and IUL integration update
23rd Nov 20177:00 amRNSInnovate UK Grant Award
30th Oct 20173:19 pmRNSDirector Appointment
18th Oct 201712:46 pmRNSHolding(s) in Company
17th Oct 201711:05 amRNSSecond Price Monitoring Extn
17th Oct 201711:00 amRNSPrice Monitoring Extension
11th Oct 20178:17 amRNSHolding(s) in Company
10th Oct 20171:55 pmRNSHolding(s) in Company
9th Oct 20173:23 pmRNSHolding(s) in Company
9th Oct 20172:51 pmRNSHolding(s) in Company
6th Oct 20178:00 amRNSCompletion of Acquisition
5th Oct 201711:18 amRNSResult of General Meeting
21st Sep 20171:31 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSContract awarded at Mohawk College in Canada
19th Sep 20173:40 pmRNSAcquisition & Placing
17th Aug 20177:00 amRNSInstallation of 500th simulation system
10th Aug 20178:37 amRNSPayment of deferred consideration
31st Jul 20177:00 amRNSHalf-year Report
24th Jul 20177:00 amRNSMedaPhor wins first ScanTrainer customer in India
23rd May 201711:44 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.